Skip to main content
Download PDF

Vitamin D intake and gastric cancer in Viet Nam: a case-control study

BMC Cancer volume 22, Article number: 838 (2022) Cite this article

Abstract

Background

Most recent laboratory studies have suggested a promising role of vitamin D and its analogs as novel chemotherapeutic agents for cancer treatment. However, epidemiological evidence, especially regarding the effects of vitamin D on gastric cancer is still inconsistent.

Objectives

Our research aimed to evaluate the associations between vitamin D intake and the risk of developing gastric cancer through a case-control study in North Vietnam.

Methods

We accessed databases of the previous completed case-control studies to derive 1182 incident gastric cancer cases and 2995 hospital controls selected from hospitals in Hanoi from 2003 to 2019. Vitamin D intake was computed by multiplying the food frequency intake with nutrient content based on the Viet Nam Food Composition Tables. Data were collected through face-to-face interviews by trained interviewers using the validated semi-quantitative food frequency and demographic lifestyle questionnaires. The odds ratio and 95% confidence interval (OR and 95%CI) were estimated using unconditional logistic regression analysis.

Results

We observed a continual decline in gastric cancer risk according to the level-up of vitamin D intake in both genders, men, and women [Fifth vs. bottom quintile, OR, 95%CI: 0.68 (0.53, 0.86), OR, 95%CI: 0.72 (0.53, 0.97), OR, 95%CI: 0.58 (0.38, 0.89), respectively. Per increment quintile, the statistically significant decreased risk was seen by 7% in men and 13% in women. The significant inverse association between vitamin D intake remained in the subgroups of ever and never tobacco smoking; negative and positive H. pylori infection.

Conclusion

The findings suggested that sufficient vitamin D intake was associated with a lower risk of Gastric Cancer in the Vietnamese population.

Peer Review reports

Introduction

Over the last decades, the overall incidence of Gastric cancer (GC) has been declining, attributed to the eradication of Helicobacter Pylori (H. pylori) and the use of refrigeration to preserve foods [1]. However, GC is still the fifth most common cancer worldwide and the third most common cause of death from cancer responsible for over 1,000,000 new cases and 783,000 deaths in 2018 [2].

The highest GC incidence was recorded in Asian countries: 1st: South Korea, 2nd: Mongolia, 3rd: Japan, 4th: China, which accounts for more than half of all cases. Viet Nam ranks 10th with 15.9 new cases per 100,000 [2]. A study on non-cardia GC conducted in the two biggest cities of Viet Nam showed a male predominance and a strong relationship with H. pylori infection [3].

GC results from a combination of lifestyle, environmental factors, and the accumulation of specific genetic alterations [4]. GC can be divided into 2 topographical subtypes: cardia and non-cardia GC. The two subtypes share common risk factors including older age, male sex, smoking, radiation, and family history [5]. Non-cardia GC has been steadily declining globally and is primarily associated with H. pylori infection, low socioeconomic status, low consumption of fruits and vegetables, and high salt intake. On the other hand, cardia-GC has been increasing particularly in high-income countries and is mainly linked to obesity and Gastroesophageal reflux disease [2, 5].

Vitamin D comprises a group of fat-soluble sitosterol hormones with two major forms of vitamin D2 and vitamin D3. D3 is made in the skin under UV light, whereas D2 is derived from the plant sterol ergosterol [6]. Both forms are metabolized first to 25 hydroxyvitamin D (25OHD or Calcidiol) in the liver, then to the biologically active hormonal form 1,25-dihydroxy vitamin D (1,25(OH)2D or Calcitriol) mainly by the kidney [6, 7]. Calcitriol is the ligand for the vitamin D receptor (VDR), a transcription factor, binding to sites in the DNA called vitamin D response elements (VDREs) [7]. Recent research found that VDRs are widely distributed throughout the body even in tissues not involved with calcium and phosphate homeostasis, while VDREs are also present in a large number of human genes involved in a wide range of classical and non-classical roles, in a cell-specific fashion [6,7,8]. The increasing evidence from studies in cell culture and experimental models suggests that vitamin D has many roles beyond calcium homeostasis that regulate multiple cellular processes such as inhibiting differentiation, metastasis, proliferation, and inducing apoptosis and cell cycle arrest [9]. These proposed mechanisms support vitamin D’s role as a potent chemotherapy agent, therefore, the interest in vitamin D and research on its suggested anti-cancer effects has greatly increased over the last decade. Our study aimed to evaluate the correlation between dietary intake of vitamin D and GC in the Vietnamese population.

Materials and methods

Study population

We derived data from databases of the previous completed case-control studies performed in the hospital located in Hanoi from 2003 to 2019. Study participants included 1182 incident gastric cancer cases and 2995 hospital controls. These previous completed case-control studies were supported by the Vietnam Ministry of Science and Technology and the investigators followed the national guidelines and regulations. The designed research protocols were approved by the scientific committees of the Hanoi Medical University [10], the Institutional Review Board of Hanoi Medical University [11], and the Ministry of Science and Technology [12, 13].

The study model consists of 1182 cases and 2995 controls selected from in-patients in hospitals, in Hanoi, Viet Nam. The cases are patients diagnosed as having GC by histopathological evaluation and confirmation. Controls included non-cancer patients in the same department during the same period. The study methods have been described and published elsewhere [11, 14].

Recruitment of cases

Gastric cancer cases were recruited from the list of patients who have been admitted to the Bach Mai hospital, Viet Duc Hospital, National Cancer hospital, and Hanoi Medical University hospital for surgical treatment to remove gastric cancer tumors for the first time. Every day, patients have entered the inpatient wards for their surgical treatment the next day. The eligible cancer patients were invited to participate in the present study and investigators have to get their voluntary agreement before interviews, face-to-face, bedside by the trained interviewers to collect data [10,11,12,13,14].

Recruitment of hospital controls

The hospital control cases were also weekly recruited from the same list of patients who have been admitted to the Bach Mai hospital for surgical treatment for non-cancer diseases. The Bach Mai hospital is located nearby the other three health facilities of Viet Duc hospital, the National cancer hospital, and Hanoi Medical University hospital where cases were recruited. These control cases were daily also checked-in at the Bach Mai hospital from 1 PM to 5 PM, patients also entered the inpatient wards for their surgical treatment on the next day. The eligible hospital controls were invited to participate in the present study and researchers have to get their voluntary agreement before interviews, face-to-face, bedside by the trained interviewers to collect data [10,11,12,13,14].

Exposure estimation

The designed Demographics & Lifestyles, Semi-Quantitative Food Frequency Questionnaires (SQFFQ) were used to collect data from all participants. SQFFQ is a validated and reproducible set of 192 questions that reflect detailed dietary habits as well as other elements that have an impact on one’s health status over 1 year. Among those, 123 questions were related to usual food items, along with sub-questions providing information about the amount, frequency, and methods of cooking of each item. Participants were interviewed by trained interviewers on the day immediately before their surgical treatment [10,11,12,13,14]. The nutrient composition of food intake was based on the Viet Nam Food Composition Tables [15]. From these data sources, we calculated the estimated total intake of each nutrient including vitamin D intake for each study participant in the present study.

Validation of the data collection tool

The SQFFQ was validated by comparing nutrient intake by two methods of 24-hour food records for three consecutive weekdays (The reference group) and the designed SQFFQ by 310 eligible study participants. The SQFFQ was completed one time during autumn 2018. The designed SQFFQ was being validated as having good characteristics of feasibility, practical, and reliability in the general populations located in North Viet Nam based on the estimated indicators of a small correlation for lipid (adjusted R2 = 0.20); a moderate correlation for protein (adjusted R2 = 0.38) and carbohydrate (adjusted R2 = 0.36), a strong correlation for energy intake (adjusted R2 = 0.53) between two methods of data collection [16].

A routine determination of H. pylori infection

The previous completed case-control studies have determined the status of H. pylori infection based on a routine laboratory test before performing surgical procedures of treatment for each case and control. Anti-H. pylori serum IgG antibody titers were tested using an enzyme-linked immunosorbent assay (ELISA), based on the sandwich principle, through the use of an H. pylori IgG ELISA kit (RE56381; IBL International, Hamburg, Germany). H. pylori status was classified into three groups, based on a cut-off index (COI) provided by the manufacturer: negative (COI < 0.8), equivocal (0.8–1.2), and positive (> 1.2) for the blood samples collected during 2018-2019. From 2003 to 2011, Anti-H. pylori serum IgG antibody titers were examined using the Pyloriset EIA-G III, Orion Diagnostica to perform the IgG ELISA test. The cut-off level of < 20 U/ml was considered a negative H. pylori status.

Statistical analysis

Odds ratio and 95% confidence interval (OR and 95%CI) were estimated using unconditional logistic regression analysis adjusted for age, education, smoking, BMI, family history of cancer, blood group (A, AB, B, O), alcohol drinking, fridge available at home, four periods of data collection, energy intake, and serum status of H. pylori infection. The OR and 95%CI were estimated for the entire study population, as well as the subgroup of ever and never tobacco smoking; negative and positive H. pylori infection.

Ethical approval

Ethics approval and consent to participate

The authors confirm to follow the study protocol that was approved by the ethics committees of the IRB-International University of Health and Welfare, Japan (Approval number 19-Ig-17) dated 27 May 2019. This study uses the database of existing previous completed case-control studies. Participants were anonymous and personal information was coded which cannot identify participants. Each participant was coded with an ID. Data is saved into a USB stick memory with a password.

All methods were performed and carried out by relevant ethical guidelines and Vietnam’s national regulations. The existing previous completed case-control studies were performed in the hospitals located in Hanoi from 2003 to 2019. The study protocol was approved by the ethics committees of Ha Noi Medical University, number 3918/HMUIRB dated 25 December 2018. We obtained verbal informed consent from all participants. Such as, for the week from 8 to 12 Jan. 2018, among the list of 81 patients admitted and were planning to be treated by surgeries at the Dept. of Surgery of Bach Mai hospital, we invited 34 of 81 patients who agreed to participate in the study as voluntary. Study participants have completed a questionnaire survey and allowed investigators access to data of routine laboratory tests of H. pylori infection and hepatitis viral infection. According to the guideline for epidemiological studies in Vietnam and Japan in 2002, written informed consent was not required for an observational study based on a questionnaire survey. Completion and return of the questionnaire were considered implied consent.

Results

By comparison between quintiles, there was a higher intake of lipid (mean 45.8 g versus 26.4 g), protein (mean 90.2 g versus 59.9 g), and energy (1806.7 Kcal versus 1638.4 Kcal) in the 5th quintile than in the 1st quintile. In contrast, carbohydrate intake was lower in the 5th quintile than in the 1st quintile (261.0 g versus 193.3 g), Table 1.

Table 1 Characteristics of demographic and macronutrients intake of quintile 1 and quintile 5
Full size table

The mean dietary vitamin D intake in the highest quintile was 11.9 μg/day, and that of the lowest quintile was 0.4 μg/day. A continual decline in cancer risk according to the increment quintile of vitamin D intake was recorded (OR and 95%CI: 0.84 (0.80-0.88), p = 0.001). After adjusting for age, education, smoking, BMI, family history of cancer, blood group (A, AB, B, O), alcohol drinking, fridge at home, four periods of data collection, energy intake, and serum status of H. pylori infection, a steady decline in adjusted ORs from each level up of vitamin D intake quintile was also observed (adjusted OR and 95%CI: 0.91 (0.86-0.96), p = 0.000). A statistically significant decreased risk of GC was found at the highest 5th quintile compared to the lowest quintile (adjusted OR and 95%CI, 5th versus 1st quintiles: 0.68 (0.53-0.86), p = 0.002), Table 2.

Table 2 Vitamin D intake and gastric cancer, men and women combined
Full size table

Stratified analysis according to sex-specific quintile also reached similar outcomes in both men and women subgroups (adjusted OR and 95%CI, 5th versus 1st quintiles: 0.72 (0.53-0.97), p = 0.028; and adjusted OR and 95%CI, 5th versus 1st quintiles: 0.58 (0.38, 0.89), p = 0.013, respectively). Again, the continual decline in cancer risk according to the increment quintile of vitamin D intake was recorded (adjusted OR and 95%CI: 0.93 (0.87, 0.99), p = 0.027 for men and adjusted OR and 95%CI: 0.87 (0.80, 0.96, p = 0.003 for women). Tables 3 and 4.

Table 3 Vitamin D intake and gastric cancer in men
Full size table
Table 4 Vitamin D intake and gastric cancer in women
Full size table

The significant inverse association between vitamin D intake remained in the subgroups of ever and never tobacco smoking; negative and positive H. pylori infection. An adjusted OR and 95%CI, 5th versus 1st quintiles: 0.41 (0.29, 0.60), p = 0.000 for never smoker; OR and 95%CI: 0.64 (0.46, 0.94), p = 0.012 for ever smoker; OR and 95%CI: 0.23 (0.13, 0.39), p = 0.000 for negative H. pylori infection; OR and 95%CI: 0.50 (0.33, 0.74, p = 0.001 for positive H. pylori infection (data not shown).

Discussions

We observed strong beneficial protection of vitamin D intake against gastric cancer in the entire study population in general and in both men and women in particular. Intake of vitamin D of the estimated amount of 11 μg/day or higher (the 5th quintile) reduced about 32% of cancer incidence, which was 28% in men and 42% in women. The beneficial effect of vitamin D intake was consistent among the entire study population with each subgroup ever and never tobacco smoking; negative and positive H. pylori infection. The findings suggested that the inverse association appeared stronger in never smoker and negative H. pylori infection groups than in ever smoker and positive H. pylori infection groups. In addition, following the recommendation of the Institute of Health (US) of a daily dietary vitamin D intake of 400-600 IU (10-15 μg) for children to adults [17], the proportion of vitamin D deficiency was about 77.6% of 2995 persons in the control group. The findings suggested that vitamin D is possibly more protective in reducing the risk of gastric cancer in women when compared to men. The mechanisms of this effect are unclear. However, Estrogen hormone in women may have a protective role in the pathogenic pathway of GC or interact with the biological activity of vitamin D or its precursors. Besides, Vietnamese men are likely to have higher exposure to tobacco smoking and alcohol drinking than women [18]. These two established risks of gastric cancer might be a modification of the association between vitamin D and gastric cancer in the present study.

The present study has many strengthening points that include a relatively large sample size of 4177 study participants, in which 1182 cancer cases and 2995 hospital controls. The database has available variables for the adjustment that were included the infectious agent of H. pylori status, lifestyles factors of tobacco smoking and alcohol drinking; the social-economic status of education, and fridge at home; the host factor of blood groups, sex, age, and family history of cancer; and other factors of body mass index and energy intake. These advantage indicators will allow us to look at the association between vitamin D intake and the risk of gastric cancer.

Vitamin D can be obtained from sun exposure, supplements, and limited naturally occurring food, including oily fish, fish liver oil, mushroom, and egg yolk [19]. Besides, dermal synthesis remains the major route, accounting for 90% of vitamin D replenishment [20]. Most foods except for fatty fish contain little vitamin D unless fortified [6]. The vitamin D in fish is D3, whereas that used for fortification is often D2 (ergocalciferol), which is produced by UVB irradiation of the ergosterol in plants and mushrooms [7]. Both D3 and D2 are synthesized commercially and found in dietary supplements or fortified foods. After vitamin D was recognized as important for the prevention of rickets in the 1920s, in the US and Canada, vitamin-D-fortification in some foods like fluid milk, margarine, yogurts, plant-based beverages, cheeses, and juices was initiated voluntarily [20]. Owing to its fat-soluble nature, dietary vitamin D is absorbed with other dietary fats in the small intestine, therefore, the efficient absorption of vitamin D is dependent upon the presence of fat in the lumen [6, 21].

Vitamin D deficiency (VDD) is now considered a worldwide health issue, not only because of its consequence in bone diseases, but also its recently discovered association with the risk of cancers, autoimmune disorders, hypertension, and infectious disease [22]. VDD is diagnosed when measured serum 25OHD < 20 ng/mL [23]. VDD has become an emerging problem in Viet Nam as the reported prevalence of VDD was 30% in females and 16% in males [24]. The Institute of Health (US) recommended a daily dietary vitamin D intake of 400 IU (10 μg) for infants, 400-600 IU (10-15 μg) for children to adults, and 400-800 IU (10-20 μg) for elderly aged over 70 [17]. These amounts of intake were made concerning bone issues in the community thus they have limited value in the interest of cancer prevention. There haven’t been evidence-based scientific studies to determine the recommended vitamin D requirement for the Vietnamese population. However, our study’s result showed that mean daily vitamin D intake in the first 4 quintiles in both men and women groups is significantly lower than 10 μg/day, which suggested a serious absence of vitamin D in Vietnamese’s usual meals that may be linked with a high prevalence of VDD in the population. However, participants tend to under-report daily consumption when answering surveys [25, 26], which may lead to a lower result than the actual intake.

As mentioned earlier, over the last few years, vitamin D and its suggested anti-cancer actions have emerged as a hot topic and gained attention from researchers. Studies in vitro and in vivo have shown inhibitory actions upon the binding of Calcitriol to the VDR for many different types of cancers. In their review, Chiang et al. also indicated that the underlying mechanisms of these effects are the VDR-dependent actions, which are mediated through the VDR-dependent transactivation of genomes, which may include anti-proliferative effects via several signaling pathways, inducing apoptosis, anti-angiogenesis, pro-differentiations, anti-inflammation, and DNA repair [27, 28]. The review also nominated non-VDR actions of Calcitriol, as an area of focus in the coming years [27]. Pan et al. reported correlation and interaction among VDR, phosphatase, and tensin homolog deleted on chromosome 10 (PTEN), and epigenetic modifiers such as 5-aza-2-deoxycytidine, trichostatin A (TSA), sodium butyrate upon binding of Calcitriol to VDR may be able to enhance the apoptosis in human GC cells [29]. Also, vitamin D, by altering the expression of genes in the extracellular matrix remodeling, can modify the tumor’s extracellular microenvironment and suppress GC’s progression [30]. Vitamin D may inhibit the expression of numerous Hedgehog signaling target genes, thus decreasing cell viability in GC cell viability [31]. Bao et al. reported that 1,25(OH)2D3 potentiates cisplatin-mediated cell growth inhibition and cell apoptosis in GC cells [32]. H. pylori infection is the major risk factor for non-cardia GC [5]. Yang et al. found that sufficient vitamin D levels could be associated with decreased H. pylori infection, which may crucially contribute to the prevention of GC [33]. Convincing laboratory evidence at the levels of cells and tissues demonstrated a promising ability of vitamin D in suppressing the tumorigenesis and progression of GC. However, the evidence of epidemiological studies remains paradoxical and inconsistent.

Recently, epidemiologic studies have attempted to prove the relationship between vitamin D status with the incidence and mortality of many types of cancer. However, the findings are conflicting. To evaluate the vitamin D status of participants, measured serum 25OHD (Calcidiol) value was most used. Raimondi et al. reported two most common VDR polymorphisms - FokI and BsmI - reduce the risk of cancer in the breast, skin, and prostate and suggested the same impact on cancer risk at any site in Caucasians [34]. Vaughan-Shaw et al. analyzed 44,165 cases from 64 non-randomized controlled trials (non-RCT) studies, suggesting that a higher serum 25OHD was associated with a 26% lower mortality and a 16% lower rate of progression in cancer patients. However, only one in 64 included studies was related to GC, and this study’s size was small [35]. Giovannucci et al. reached a similar conclusion for total cancers, and a non–statistically significant but suggestive inverse association for GC was recorded [36]. A prospective cohort study from China showed that higher serum 25(OH) D levels had no association with the risk of GC [37]. However, the study model has a relatively low population mean serum 25OHD level, and the mean follow-up time was short (5.25 years). Moreover, after obtaining pre-trial serum 25OHD, they did not collect any follow-up samples. Other non-RCT studies indicated lower serum 25OHD may be a contributory risk for both predisposition and development of GC and associated with poor clinical outcomes [9, 38,39,40]. The studies assessing vitamin D intake are few. Khayatzadeh et al. analyzed data from 4 case-control studies and found no evidence for the significant association between vitamin D intake as well as serum 25OHD level and risk of GC [41,42,43,44,45]. However, the total study population was small, mainly in Western countries, and the results were inconsistent. Eom Et al investigated 715 pairs of newly diagnosed GC patients and controls in Korea and found no statistically significant interactions between vitamin D intake and risk of GC [46].

Inaccurate assessment of vitamin D status could overstate, or underestimate its relation to tumor development. Although serum 25OHD concentration is a useful biological parameter for assessing current vitamin D status, it constantly varies depending on serum Calcium and Parathyroid hormone (PTH) level, season, and comparability of assays for serum 25OHD [47]. Serum 25OHD measured at a specific moment may not reflect one’s status of vitamin D exposure for a long time. Published data from many studies did not provide time between the measurement of 25OHD and the diagnosis of cancer [48]. Besides, medical treatment and modification in patient’s outdoor sunlight exposure, physical activity, and daily diet after the diagnosis of cancer may reversely result in lower 25OHD levels, thus, a cause-effect association cannot be established [46, 49].

To overcome these issues, some studies, including ours, used estimated vitamin D intake instead. Still, the method also has its weaknesses. The accuracy of estimated intake varies by participants’ abilities to recall types of foods, amount consumed, and frequency of intake. To improve the accuracy, strict follow-up and repeated detailed surveys are desired, despite it will cost vast human resources and financial costs, especially when performing on a large study population in a long observation period. Besides, evaluating the nutrient composition of each type of food and developing a comprehensive survey are also challenging. Also, respondents tend to under-report their consumption, which may lead to a lower result compared to actual intake and the need for precise reassessment [25, 26].

Evidence from epidemiological studies remains controversial, and a causal relationship cannot be built solely from non-RCT study findings. Other micronutrients (e.g., beta carotene, vitamins C and E, folic acid, and selenium) showed their potential in observational studies but failed to prove their anti-cancer effect in RCTs, and some even cause harm at high doses [49]. However, they found no solid data from RCTs to confirm the interrelation between vitamin D status and GC, as GC was the pre-specified outcome. A recently updated meta-analysis of RCTs showed that vitamin D supplementation was associated with 13% reduced total cancer mortality over 3–10 years of follow-up, but not associated with a lower cancer incidence [50]. Still, the heterogeneity in pooled results from types of cancer with dissimilar risk factors was the main weakness. Recent results of the vitamin D status using serum 25-hydroxyvitamin D and gastric cancer, a cross-sectional study in Koreans have confirmed a strong beneficial effect against cancer [38]. A recent review published in 2022 summarized results from observational studies and ten RCTs to review the relation between vitamin D and cancer and showed that RCTs have not been able to confirm findings from observational studies [51]. Two most recent RCTs (in the US in 2019 and in Australia in 2022) showed no beneficial effect of vitamin D supplementation on the incidence or mortality of cancers [52, 53]. However, these studies were conducted on healthy populations with unknown vitamin D deficiency status, and the outcomes were not specific for GC. Furthermore, the intervention duration (5.3 years and 5 years, respectively) and post-intervention follow-up duration (2 years and 5.7 years, respectively) were short. Interestingly, a subgroup analysis of the RCT conducted in the US showed that participants with BMI < 25 kg/m2 had a significantly reduced risk of cancer from vitamin D supplementation [53]. The findings may suggest the beneficial effect of vitamin D against cancer on populations with a low prevalence of obesity, such as the Vietnamese population [54].

The present study has several weaknesses. As discussed above, using an estimated vitamin D intake for the assessment of vitamin D status may not be the optimal method. We did not evaluate other determinants of human vitamin D status such as serum 25OHD concentration, supplements, calcium and PTH levels, skin pigmentation, and sunlight exposure. Despite some limitations, our study suggested low dietary intake of vitamin D may associate with an increased risk of GC in the Vietnamese population. We suggest physicians should assess the vitamin D status of GC patients and consider an appropriate supplement and healthy diet if needed. Nevertheless, further research is needed. We recommend well-designed RCTs with GC as the pre-specified outcome, along with improvements in assessment methods of human vitamin D status, and inclusion of other essential factors such as sunlight exposure. Our study also indicated a low dietary intake of vitamin D in the Vietnamese population, which may lead to a high prevalence of bone-related diseases and perhaps cancer, cardiovascular disease, diabetes, and autoimmune disorders as well [49]. We urge a national plan to improve the nutritional quality of people’s diets.

Availability of data and materials

The datasets are available from the corresponding author on reasonable request.

Abbreviations

BMI:

Body mass index

GC:

Gastric cancer

OR (95%CI):

Odds ratio (95% confidence interval)

S.D.:

Standard Deviation

SQFFQ:

A semi-quantitative food frequency questionnaire

VDD:

Vitamin D deficiency

References

  1. WCRF: Food, Nutrition, physical activity, and the prevention of Cancer: a global perspective. In. Washington DC AICR: World Cancer Research Fund / American Institute for Cancer Research; 2007.

  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    PubMed  Google Scholar 

  3. Binh TT, Tuan VP, Dung HDQ, Tung PH, Tri TD, Thuan NPM, et al. Advanced non-cardia gastric cancer and Helicobacter pylori infection in Vietnam. Gut Pathog. 2017;9:46.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric Cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiology Biomarkers & Prevention. 2014;23(5):700–13.

    Article  Google Scholar 

  6. Committee IoMU: review dietary reference intakes for vitamin D and calcium. Session 3: overview of vitamin D. Washington (DC): National Academies Press (US); 2011.

  7. Bikle Daniel D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011;25(4):543–59.

    Article  CAS  PubMed  Google Scholar 

  9. Vyas N, Companioni RC, Tiba M, Alkhawam H, Catalano C, Sogomonian R, et al. Association between serum vitamin D levels and gastric cancer: a retrospective chart analysis. World J Gastrointest Oncol. 2016;8(9):688–94.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lai TMH: Dietary factors and stomach cancer in the North of Viet Nam. Formal scientific master thesis of science in public health. Department of Occupational Health: Hanoi Medical University; 2006-2007. p. 2011.

    Google Scholar 

  11. Phuoc LH, Sengngam K, Ogawa T, Ngatu RN, Ikeda S, Hoc TH, et al. Fruit and vegetable intake and gastric cancer among male adults: a case-control study in northern Viet Nam. Asian Pac J Cancer Prev. 2020;21:2109–15.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Le TN, Pham VP. Development and validation of research instruments for observational studies on health sciences in Viet Nam. In: Vietnam Ministry of Science and Technology: Hanoi Medical University; 2020. p. 100.

  13. Thu NT, Le TN. Molecular case-control study on stomach and colorectal cancers. In: In. National Agency for science and technology information: Hanoi Medical University; 2012. p. 127.

  14. Lai HTM, Koriyama C, Tokudome S, Tran HH, Tran LT, Nandakumar A, et al. Waterpipe tobacco smoking and gastric Cancer risk among Vietnamese men. PLoS One. 2016;11(11):e0165587.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Ministry of Health. National Institute of Nutrition: Vietnamese Food Composition Table. Hanoi city: Medical Publishing House; 2007.

  16. Le TN, Le XH, Pham VP, Nguyen QD, Tran HH, Pham TO, et al. Reproducibility of a designed semi-quantitative food frequency questionnaire in general populations in the North Viet Nam. Southeast-Asian J of Sciences. 2018;6:188–97.

    Google Scholar 

  17. Committee IoMU: review dietary reference intakes for vitamin D and calcium. Session 5: dietary reference intakes for adequacy: calcium and vitamin D. Washington (DC): National Academies Press (US); 2011.

  18. Van Minh H, Giang KB, Ngoc NB, Hai PT, Huyen DT, Khue LN, et al. Prevalence of tobacco smoking in Vietnam: findings from the global adult tobacco survey 2015. Int J Public Health. 2017;62(Suppl 1):121–9.

    Article  PubMed  Google Scholar 

  19. Chang SW, Lee HC. Vitamin D and health - the missing vitamin in humans. Pediatr Neonatol. 2019;60(3):237–44.

    Article  PubMed  Google Scholar 

  20. Antonucci R, Locci C, Clemente MG. Vitamin D deficiency in childhood: old lessons and current challenges. 2018;31(3):247–60.

  21. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest. 1993;91(6):2552–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080s–6s.

    Article  CAS  PubMed  Google Scholar 

  23. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73–8.

    Article  PubMed  Google Scholar 

  24. Nguyen HT, von Schoultz B, Nguyen TV, Dzung DN, Duc PT, Thuy VT, et al. Vitamin D deficiency in northern Vietnam: prevalence, risk factors, and associations with bone mineral density. Bone. 2012;51(6):1029–34.

    Article  CAS  PubMed  Google Scholar 

  25. Committee IoMU: review dietary reference intakes for vitamin D and calcium. Session 7: dietary intake assessment. Washington (DC): National Academies Press (US); 2011.

  26. Dwyer J, Picciano MF, Raiten DJ. Estimation of usual intakes: what we eat in America-NHANES. J Nutr. 2003;133(2):609s–23s.

    Article  PubMed  Google Scholar 

  27. Chiang KC, Chen TC. The anti-cancer actions of vitamin D. Anti Cancer Agents Med Chem. 2013;13(1):126–39.

    Article  CAS  Google Scholar 

  28. Deeb KK, Trump DL, Johnson CS. Vitamin D signaling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684–700.

    Article  CAS  PubMed  Google Scholar 

  29. Pan L, Matloob AF, Du J, Pan H, Dong Z, Zhao J, et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin a /sodium butyrate-induced and 5-aza-2’-deoxycytidine-induced PTEN upregulation. FEBS J. 2010;277(4):989–99.

    Article  CAS  PubMed  Google Scholar 

  30. Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol. 2009;200(2):207–21.

    Article  CAS  PubMed  Google Scholar 

  31. Hargrove L, Francis T, Francis H. Vitamin D and GI cancers: shedding some light on dark diseases. Ann Transl Med. 2014;2(1):9.

    PubMed  PubMed Central  Google Scholar 

  32. Bao A, Li Y, Tong Y, Zheng H, Wu W, Wei C. 1,25-Dihydroxyvitamin D3 and cisplatin synergistically induce apoptosis and cell cycle arrest in gastric cancer cells. Int J Mol Med. 2014;33(5):1177–84.

    Article  CAS  PubMed  Google Scholar 

  33. Yang L, He X, Li L, Lu C. Effect of vitamin D on Helicobacter pylori infection and eradication: a meta-analysis. Helicobacter. 2019;24(5):e12655.

    Article  CAS  PubMed  Google Scholar 

  34. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30(7):1170–80.

    Article  CAS  PubMed  Google Scholar 

  35. Vaughan-Shaw PG, O'Sullivan F, Farrington SM, Theodoratou E, Campbell H, Dunlop MG, et al. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer. 2017;116(8):1092–110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451–9.

    Article  CAS  PubMed  Google Scholar 

  37. Chen W, Dawsey SM, Qiao YL, Mark SD, Dong ZW, Taylor PR, et al. Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer. 2007;97(1):123–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kwak JH, Paik JK. Vitamin D status and gastric Cancer: a cross-sectional study in Koreans. Nutrients. 2020;12(7).

  39. Durak Ş, Gheybi A, Demirkol Ş, Arıkan S, Zeybek ŞÜ, Akyüz F, et al. The effects of serum levels, and alterations in the genes of binding protein and receptor of vitamin D on gastric cancer. Mol Biol Rep. 2019;46(6):6413–20.

    Article  CAS  PubMed  Google Scholar 

  40. Ren C, Qiu MZ, Wang DS, Luo HY, Zhang DS, Wang ZQ, et al. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med. 2012;10:16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Khayatzadeh S, Feizi A, Saneei P, Esmaillzadeh A. Vitamin D intake, serum vitamin D levels, and risk of gastric cancer: a systematic review and meta-analysis. J Res Med Sci. 2015;20(8):790–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Pelucchi C, Tramacere I, Bertuccio P, Tavani A, Negri E, La Vecchia C. Dietary intake of selected micronutrients and gastric cancer risk: an Italian case-control study. Ann Oncol. 2009;20(1):160–5.

    Article  CAS  PubMed  Google Scholar 

  43. Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomark Prev. 2001;10(10):1055–62.

    CAS  Google Scholar 

  44. Cornée J, Pobel D, Riboli E, Guyader M, Hémon B. A case-control study of gastric cancer and nutritional factors in Marseille. France Eur J Epidemiol. 1995;11(1):55–65.

    Article  PubMed  Google Scholar 

  45. La Vecchia C, Ferraroni M, D'Avanzo B, Decarli A, Franceschi S. Selected micronutrient intake and the risk of gastric cancer. Cancer Epidemiol Biomark Prev. 1994;3(5):393–8.

    Google Scholar 

  46. Eom SY, Yim DH, Kim DH, Yun HY, Song YJ, Youn SJ, et al. Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea. J Biomed Res. 2018;32(4):257–63.

    PubMed  PubMed Central  Google Scholar 

  47. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol. 2004;89-90(1-5):611–4.

    Article  CAS  PubMed  Google Scholar 

  48. Trowbridge R, Mittal SK, Agrawal DK. Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence. Cancer Epidemiol Biomark Prev. 2013;22(6):1007–14.

    Article  CAS  Google Scholar 

  49. Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of Cancer — ready for prime time? N Engl J Med. 2011;364(15):1385–7.

    Article  CAS  PubMed  Google Scholar 

  50. Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Munoz A, Grant WB. Vitamin D and Cancer: an historical overview of the epidemiology and mechanisms. Nutrients. 2022;14(7).

  52. Neale RE, Baxter C, Romero BD, McLeod DSA, English DR, Armstrong BK, et al. The D-health trial: a randomized controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. 2022;10(2):120–8.

    Article  CAS  PubMed  Google Scholar 

  53. Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Vitamin D supplements and prevention of Cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44.

    Article  CAS  PubMed  Google Scholar 

  54. Nguyen TT, Hoang MV. Non-communicable diseases, food, and nutrition in Vietnam from 1975 to 2015: the burden and national response. Asia Pac J Clin Nutr. 2018;27(1):19–28.

    PubMed  Google Scholar 

Download references

Acknowledgments

We have deeply appreciated staff members of Bach Mai and National Cancer hospitals, and Hanoi Medical University hospital for their valuable support in conducting the study. We especially thank patients for participating in the present study and providing information on their dietary habits and lifestyles.

Funding

The Grant Agreement No.: 18/FIRST/1a/HMU, Under the Project: “Fostering Innovation through Research, Science and Technology”, during 2017-2019; Viet Nam Ministry of Science and Technology, during 2006-2011.

Author information

Authors and Affiliations

  1. School of Medicine, International University of Health and Welfare, Narita City, Japan

    Minh Thien Nguyen, Nhi Ngoc Yen Huynh, Dai Duc Nguyen, Nguyen Ha Ta, Tai Van Nguyen & Huy Thanh Dang

  2. Institute of Research and Development, Duy Tan University, Da Nang City, Viet Nam

    Ngoan Tran Le

  3. Department of Public Health, School of Medicine, International University of Health and Welfare, Narita City, Japan

    Ngoan Tran Le

Authors
  1. Minh Thien Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nhi Ngoc Yen Huynh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dai Duc Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nguyen Ha Ta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tai Van Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Huy Thanh Dang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ngoan Tran Le
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors reviewed the manuscript and contributed revisions. NTL, MTN, DDN, HNYN, HTD, TVN, and NHT were mainly responsible for drafting, revision, and analysis. NTL, MTN was principally responsible for data collection. NTL, MTN, DDN, and HNYN extracted data and were mainly responsible for managing and analyzing data. NTL, MTN, DDN, HNYN, HTD, TVN, and NHT were major contributors to writing the manuscript. All authors approved the version for publication.

Corresponding author

Correspondence to Ngoan Tran Le.

Ethics declarations

Ethics approval and consent to participate

The authors confirm to follow the study protocol that was approved by the ethics committees of the IRB-International University of Health and Welfare, Japan (Approval number 19-Ig-17) dated 27 May 2019. This study uses the database of existing previous completed case-control studies. Participants were anonymous and personal information was coded which cannot identify participants. Each participant was coded with an ID. Data is saved into a USB stick memory with a password.

For the existing previous completed case-control studies All methods were performed and carried out by-relevant ethical guidelines and Vietnam’s national regulations. The existing previous completed case-control studies were performed in the hospitals located in Hanoi from 2003 to 2019. We obtained verbal informed consent from all participants and the study protocol was approved by the Institution Review Board for Ethics in Biomedical Research - Ha Noi Medical University has agreed to approve, number 3918/HMUIRB dated 25 December 2018. Such as, for the week from 8 to 12 Jan. 2018, among the list of 81 patients admitted and were planning to be treated by surgeries at the Dept. of Surgery of Bach Mai hospital, we invited 34 of 81 patients agreed to participate in the study as voluntary. Study participants have completed a questionnaire survey and allowed investigators access to data of routine laboratory tests of H. pylori infection and hepatitis viral infection. According to the guideline for epidemiological studies in Vietnam and Japan in 2002, written informed consent was not required for an observational study based on a questionnaire survey. Completion and return of the questionnaire were considered implied consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nguyen, M.T., Huynh, N.N.Y., Nguyen, D.D. et al. Vitamin D intake and gastric cancer in Viet Nam: a case-control study. BMC Cancer 22, 838 (2022). https://doi.org/10.1186/s12885-022-09933-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-022-09933-2

Keywords

BMC Cancer

ISSN: 1471-2407

Contact us